Economic Evaluation of Baroreceptor STIMulation for the Treatment of Resistant HyperTensioN
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 132 participants.
Also called NCT02364310
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 132 participants
- Sponsor
- Pr Patrick ROSSIGNOL
- Registry
-
NCT02364310
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT02364310. Randomized; no masking; primary purpose treatment. Start 2015-03-31 (actual); primary completion 2021-06-22 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Economic Evaluation of Baroreceptor STIMulation for the Treatment of Resistant HyperTensioN
- Acronym
- ESTIM-rHTN
- Condition
- Hypertension
- Intervention (Device)
- Baroreceptor stimulation with Barostim Neo TM
- Lead sponsor
- Pr Patrick ROSSIGNOL
Record details
- Record id
cardio:ct-nct02364310- Content hash
1c5b829d4efbb19403c1835b672d1a0b3716dd2de235cf56cfd6caeda6a36993